Clinical Trial Update: Observational Study in Patients With Schizophrenia Treated With Long-Acting Risperidone Injection (RISPERDAL CONSTA)

View source ↗

Summary

An observational study assessing outcomes in schizophrenia patients treated with the long-acting injectable risperidone (RISPERDAL CONSTA) has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia

Drugs mentioned

• Risperdal Consta (risperidone long-acting injectable)

Snippet

Sponsor: Janssen, LP | Conditions: Schizophrenia | Status: COMPLETED